Zobrazeno 1 - 10
of 332
pro vyhledávání: '"Mallett CP"'
Autor:
Sacconnay L; GSK, 1330 Rixensart, Belgium., De Smedt J; GSK, 1330 Rixensart, Belgium., Rocha-Perugini V; GSK, 1330 Rixensart, Belgium., Ong E; GSK, 1330 Rixensart, Belgium., Mascolo R; GSK, 1330 Rixensart, Belgium., Atas A; GSK, 1330 Rixensart, Belgium., Vanden Abeele C; GSK, 1300 Wavre, Belgium., de Heusch M; GSK, 1300 Wavre, Belgium., De Schrevel N; GSK, 1330 Rixensart, Belgium., David MP; GSK, 1300 Wavre, Belgium., Bouzya B; GSK, 1300 Wavre, Belgium., Stobbelaar K; Department of Biomedical Sciences and Infla-Med Centre of Excellence, University of Antwerp, 2610 Wilrijk, Belgium., Vanloubbeeck Y; GSK, 1330 Rixensart, Belgium., Delputte PL; Department of Biomedical Sciences and Infla-Med Centre of Excellence, University of Antwerp, 2610 Wilrijk, Belgium., Mallett CP; GSK, Rockville, MD 20850, USA., Dezutter N; GSK, 1300 Wavre, Belgium., Warter L; GSK, 1330 Rixensart, Belgium.
Publikováno v:
Science translational medicine [Sci Transl Med] 2023 Aug 23; Vol. 15 (710), pp. eadg6050. Date of Electronic Publication: 2023 Aug 23.
Autor:
Williams JA; GSK, Rockville, MD, USA., Biancucci M; GSK, Rockville, MD, USA., Lessen L; GSK, Rockville, MD, USA., Tian S; GSK, Rockville, MD, USA., Balsaraf A; GSK, Rockville, MD, USA., Chen L; GSK, Rockville, MD, USA., Chesterman C; GSK, Rockville, MD, USA., Maruggi G; GSK, Rockville, MD, USA., Vandepaer S; GSK, Rockville, MD, USA., Huang Y; GSK, Rockville, MD, USA., Mallett CP; GSK, Rockville, MD, USA., Steff AM; GSK, Rockville, MD, USA., Bottomley MJ; GSK, Rockville, MD, USA., Malito E; GSK, Rockville, MD, USA., Wahome N; GSK, Rockville, MD, USA., Harshbarger WD; GSK, Rockville, MD, USA.
Publikováno v:
Science advances [Sci Adv] 2023 Jun 09; Vol. 9 (23), pp. eadg0330. Date of Electronic Publication: 2023 Jun 07.
Autor:
Levine MZ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Holiday C; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Bai Y; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Zhong W; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Liu F; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Jefferson S; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Gross FL; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Tzeng WP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Fries L; Novavax, Inc., Gaithersburg, MD 20878, USA., Smith G; Novavax, Inc., Gaithersburg, MD 20878, USA., Boutet P; GSK, 1300 Wavre, Belgium., Friel D; GSK, 1300 Wavre, Belgium., Innis BL; GSK, Rockville, MD 20850, USA., Mallett CP; GSK, Rockville, MD 20850, USA., Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., York IA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Tumpey T; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Nov 01; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 01.
Autor:
Schotsaert M; Global Health and Emerging Pathogens Institute, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Cox RJ; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway., Mallett CP; GSK, Rockville, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 18; Vol. 13, pp. 980956. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).
Autor:
Folschweiller N; GSK, Wavre, Belgium; Takeda Pharmaceuticals, Zurich, Switzerland. Electronic address: nicolas.folschweiller@takeda.com., Vanden Abeele C; GSK, Wavre, Belgium., Chu L; Benchmark Research, Austin, TX, USA., Van Damme P; University of Antwerp, Centre for the Evaluation of Vaccination, Antwerp, Belgium., García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Moderna, Cambridge, MA, USA., Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Solórzano A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Pfizer, Pearl River, NY, USA., Bi D; GSK, Wavre, Belgium., David MP; GSK, Wavre, Belgium., Friel D; GSK, Wavre, Belgium., Innis BL; GSK, King of Prussia, PA, USA; PATH, Washington, DC, USA., Koch J; GSK, Wavre, Belgium; UCB, Brussels, Belgium., Mallett CP; GSK, Rockville, MD, USA., Rouxel RN; GSK, Rixensart, Belgium; MSD Animal Health, Bergen, Norway., Salaun B; GSK, Rixensart, Belgium., Vantomme V; GSK, Wavre, Belgium., Verheust C; GSK, Wavre, Belgium., Struyf F; GSK, Wavre, Belgium; Janssen Research and Development, Beerse, Belgium.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jul; Vol. 22 (7), pp. 1062-1075. Date of Electronic Publication: 2022 Apr 21.
Autor:
Maruggi G; GSK, Rockville, MD 20850, USA. Electronic address: giulietta.x.maruggi@gsk.com., Mallett CP; GSK, Rockville, MD 20850, USA., Westerbeck JW; GSK, Rockville, MD 20850, USA., Chen T; GSK, Rockville, MD 20850, USA., Lofano G; GSK, Rockville, MD 20850, USA., Friedrich K; GSK, Rockville, MD 20850, USA., Qu L; GSK, Rockville, MD 20850, USA., Sun JT; GSK, Rockville, MD 20850, USA., McAuliffe J; GSK, Rockville, MD 20850, USA., Kanitkar A; GSK, Rockville, MD 20850, USA., Arrildt KT; GSK, Rockville, MD 20850, USA., Wang KF; GSK, Rockville, MD 20850, USA., McBee I; GSK, Rockville, MD 20850, USA., McCoy D; GSK, Upper Providence, PA 19426, USA., Terry R; GSK, Ware, Hertfordshire SG12 ODP, UK., Rowles A; GSK, Ware, Hertfordshire SG12 ODP, UK., Abrahim MA; Charles River Laboratories, Laval, QC H7V 4B3, Canada., Ringenberg MA; GSK, Upper Providence, PA 19426, USA., Gains MJ; Charles River Laboratories, Laval, QC H7V 4B3, Canada., Spickler C; Charles River Laboratories, Laval, QC H7V 4B3, Canada., Xie X; Depatment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA., Zou J; Depatment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA., Shi PY; Depatment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA., Dutt T; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80521, USA., Henao-Tamayo M; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80521, USA., Ragan I; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80521, USA., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80521, USA., Johnson R; GSK, Rockville, MD 20850, USA., Nuti S; GSK, Rockville, MD 20850, USA., Luisi K; GSK, Rockville, MD 20850, USA., Ulmer JB; GSK, Rockville, MD 20850, USA., Steff AM; GSK, Rockville, MD 20850, USA., Jalah R; GSK, Rockville, MD 20850, USA., Bertholet S; GSK, Rockville, MD 20850, USA., Stokes AH; GSK, Upper Providence, PA 19426, USA., Yu D; GSK, Rockville, MD 20850, USA. Electronic address: dyu@dynavax.com.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 May 04; Vol. 30 (5), pp. 1897-1912. Date of Electronic Publication: 2022 Jan 03.
Autor:
Stadlbauer D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Waal L; Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands., Beaulieu E; GSK, Laval, QC, Canada.; Nexelis, Laval, QC, Canada., Strohmeier S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria., Kroeze EJBV; Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands., Boutet P; GSK, Wavre, Belgium., Osterhaus ADME; Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands.; The Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine, Hannover, Germany., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Innis BL; GSK, King of Prussia, PA, USA.; PATH, Center for Vaccine Innovation and Access, Washington, DC, USA., Nachbagauer R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Moderna Inc., Cambridge, MA, USA., Stittelaar KJ; Viroclinics Biosciences B.V., Viroclinics Xplore, Schaijk, The Netherlands.; Wageningen Bioveterinary Research, Wageningen University & Research, Lelystad, The Netherlands., Mallett CP; GSK, Laval, QC, Canada. corey.p.mallett@gsk.com.; GSK, Rockville, MD, USA. corey.p.mallett@gsk.com.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2021 Mar 19; Vol. 6 (1), pp. 40. Date of Electronic Publication: 2021 Mar 19.
Autor:
Yang, Ruohan1 (AUTHOR), Cui, Jiuwei1 (AUTHOR) cuijw@jlu.edu.cn
Publikováno v:
Molecular Cancer. 10/9/2024, Vol. 23 Issue 1, p1-12. 12p.
Autor:
Lu, Ruei-Min1 (AUTHOR), Hsu, Hsiang-En1 (AUTHOR), Perez, Ser John Lynon P.1 (AUTHOR), Kumari, Monika2 (AUTHOR), Chen, Guan-Hong1 (AUTHOR), Hong, Ming-Hsiang1 (AUTHOR), Lin, Yin-Shiou1 (AUTHOR), Liu, Ching-Hang1 (AUTHOR), Ko, Shih-Han1 (AUTHOR), Concio, Christian Angelo P.3 (AUTHOR), Su, Yi-Jen2 (AUTHOR), Chang, Yi-Han1 (AUTHOR), Li, Wen-Shan1,3 (AUTHOR) wenshan@gate.sinica.edu.tw, Wu, Han-Chung1,2 (AUTHOR) hcw0928@gate.sinica.edu.tw
Publikováno v:
Journal of Biomedical Science. 9/10/2024, Vol. 31 Issue 1, p1-36. 36p.
Autor:
Harshbarger W; GSK, Rockville, MD, United States of America., Tian S; GSK, Rockville, MD, United States of America., Wahome N; GSK, Rockville, MD, United States of America., Balsaraf A; GSK, Rockville, MD, United States of America., Bhattacharya D; GSK, Rockville, MD, United States of America., Jiang D; GSK, Rockville, MD, United States of America., Pandey R; GSK, Rockville, MD, United States of America., Tungare K; GSK, Rockville, MD, United States of America., Friedrich K; GSK, Rockville, MD, United States of America., Mehzabeen N; GSK, Rockville, MD, United States of America., Biancucci M; GSK, Rockville, MD, United States of America., Chinchilla-Olszar D; GSK, Rockville, MD, United States of America., Mallett CP; GSK, Rockville, MD, United States of America., Huang Y; GSK, Rockville, MD, United States of America., Wang Z; GSK, Rockville, MD, United States of America., Bottomley MJ; GSK, Rockville, MD, United States of America., Malito E; GSK, Rockville, MD, United States of America., Chandramouli S; GSK, Rockville, MD, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2020 Nov 02; Vol. 16 (11), pp. e1008943. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).